Journal of Biophotonics is a prestigious academic journal published by WILEY-V C H VERLAG GMBH in Germany, dedicated to advancing the field of biophotonics through high-quality research. With an ISSN of 1864-063X and an E-ISSN of 1864-0648, this journal is recognized for its contributions within diverse categories, including biochemistry, genetics, molecular biology, chemistry, engineering, materials science, and physics, earning a commendable Q2 ranking in several of these fields as of 2023. The journal aims to bridge the gap between theoretical research and practical applications, fostering interdisciplinary collaboration that is critical for innovations in imaging, diagnostics, and therapeutics. Researchers, professionals, and students alike will find the Journal of Biophotonics invaluable for staying informed about the latest developments and breakthroughs in this dynamic field, making it a cornerstone for knowledge dissemination and scholarly discourse from its inception in 2008 and continuing through 2024.

Cancer Treatment Reviews, published by Elsevier Science Ltd, is a leading international journal dedicated to the exploration and advancement of therapeutic strategies in oncology. With an impressive impact factor that reflects its status in the field, this journal is classified within Q1 quartile rankings in Medicine (Miscellaneous), Oncology, and Radiology, Nuclear Medicine and Imaging, as of 2023. The journal has a rich lineage, having been established in 1974 and consistently evolving to encompass the latest breakthroughs and methodologies in cancer treatment. A vital resource for researchers, clinicians, and students alike, it aims to promote understanding and application of effective interventions, thereby contributing to improvements in patient outcomes. By prioritizing high-quality reviews, Cancer Treatment Reviews plays an essential role in bridging the gap between current research and clinical practice, making it an indispensable asset in the continuous fight against cancer.

JOURNAL OF PORPHYRINS AND PHTHALOCYANINES, published by WORLD SCIENTIFIC PUBL CO PTE LTD, is an influential peer-reviewed journal dedicated to advancing the field of porphyrins and phthalocyanines, key compounds in both chemistry and materials science. With an ISSN of 1088-4246 and an E-ISSN of 1099-1409, this journal has been a vital resource since its inception in 1997 and is expected to continue until 2024. The journal holds a respectable position in the academic landscape, categorized in the Q3 quartile for miscellaneous Chemistry journals and ranked #252 out of 408 in the general chemistry category according to Scopus, reflecting a growing impact in the field despite its current percentile standing at 38th. JOURNAL OF PORPHYRINS AND PHTHALOCYANINES seeks to publish original research articles, reviews, and critical studies that explore the synthesis, characterization, and applications of these versatile compounds, which play essential roles in numerous scientific disciplines, from catalysis to materials development. This journal is an indispensable platform for researchers and professionals seeking to disseminate their findings, engage with contemporary discussions, and stay informed about cutting-edge advancements in porphyrin and phthalocyanine research.

Blood Cancer Discovery is a premier academic journal published by the American Association for Cancer Research, dedicated to advancing the understanding of hematologic malignancies through cutting-edge research in the fields of oncology, biochemistry, and molecular biology. With an impressive impact factor and recognition as a Q1 journal across multiple disciplines, including cancer research and hematology, Blood Cancer Discovery serves as an essential platform for scholars and practitioners alike, facilitating impactful discourse and dissemination of pioneering findings. This open-access journal, established within the vibrant academic landscape of the United States, aims to bridge gaps in research and foster collaborations to ultimately enhance patient outcomes. Its Scopus rankings demonstrate its vital role in the critical advancement of cancer research and therapeutic development. By inviting contributions from a diverse range of disciplines, Blood Cancer Discovery is poised to drive innovation and inspire future advancements in understanding blood cancers.

Optics and Spectroscopy is a pivotal peer-reviewed journal published by Pleiades Publishing Inc, focusing on the intricate fields of atomic and molecular physics, as well as optics. Established in 1972, and enjoying a legacy of convergence periods that reinforce its commitment to the evolving landscape of these scientific domains, the journal aims to disseminate high-quality research that advances our understanding of light-matter interactions, electronic materials, and spectroscopic techniques. Despite its current Q4 categorization in both the Atomic and Molecular Physics and Electronic, Optical and Magnetic Materials fields, with corresponding Scopus rankings reflecting its developing influence, the journal remains a valuable resource for researchers and professionals seeking to publish their findings, explore new methodologies, and connect with a community dedicated to innovation in optics. Although there is currently no open access option, the journal's expansive readership and its stability in publication over the decades make it an important platform for both established and emerging researchers in the field.

Optica Pura y Aplicada, published by the SOC ESPANOLA OPTICA, stands as a vital platform for the dissemination of cutting-edge research in the fields of Atomic and Molecular Physics, Optics, and related engineering disciplines. Established in Spain, this journal aims to foster the advancement of knowledge in optical science and technology by providing a rigorous peer-reviewed publication outlet for scholars, researchers, and practitioners. Despite being categorized in the Q4 quartile across multiple domains, including Engineering and Materials Science, the journal remains committed to contributing meaningful insights and advancements within its scope. With an ISSN of 0030-3917 and an E-ISSN of 2171-8814, the journal effectively reaches a global audience eager to explore innovative applications and theoretical developments in optics and materials science. Researchers and professionals alike will find in Optica Pura y Aplicada a valuable resource for enriching their understanding and practices in an ever-evolving field, fostering collaborations and promoting research growth until its converged conclusion in 2024.

Translational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.

EXPERT OPINION ON BIOLOGICAL THERAPY, published by Taylor & Francis Ltd, is a prestigious journal that has been a cornerstone in the fields of Clinical Biochemistry, Drug Discovery, and Pharmacology since its inception in 2001. With an impressive impact factor reflecting Q1 status across its categories in 2023, this journal is ranked among the top in both the pharmacology and biochemistry domains, featuring in the 81st and 77th percentiles respectively. This makes it an essential resource for researchers, professionals, and students who are keen on staying at the forefront of biological therapy advancements. The journal encompasses a broad yet focused scope, providing valuable insights into innovative therapeutic strategies and drug development methodologies. Researchers benefit from the rigorous peer-review process and the opportunity to disseminate their findings to a global audience, without the constraints of open access, ensuring the integrity and prestige of published work. As it converges towards 2024, EXPERT OPINION ON BIOLOGICAL THERAPY remains an influential platform for fostering collaboration and discussion in the evolutionary landscape of biological therapies.

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY is a prestigious academic journal published by Elsevier Science SA in the Netherlands, focusing on the interdisciplinary domains of photochemistry and photobiology. With a notable impact factor and distinguished recognition across multiple disciplines, including Q1 rankings in Biophysics, Radiation, and Radiological and Ultrasound Technology, this journal is at the forefront of research dissemination in its field. The publication spans over three decades, from 1987 to 2024, reflecting its long-standing commitment to advancing knowledge in areas critical to both fundamental and applied science. Researchers and professionals are encouraged to submit original research articles, reviews, and short communications that explore the interactions between light and biological systems, with the aim of fostering innovative solutions impacting health and technology. Although it operates on a subscription model, this journal remains a vital resource for all those engaged in the scientific exploration of these dynamic fields.